Renaissance Technologies’s TScan Therapeutics TCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.15M Buy
792,056
+622,350
+367% +$902K ﹤0.01% 2434
2025
Q1
$234K Buy
169,706
+159,106
+1,501% +$220K ﹤0.01% 3027
2024
Q4
$32.2K Sell
10,600
-63,400
-86% -$193K ﹤0.01% 3444
2024
Q3
$369K Sell
74,000
-6,000
-8% -$29.9K ﹤0.01% 2902
2024
Q2
$468K Buy
80,000
+33,000
+70% +$193K ﹤0.01% 2718
2024
Q1
$373K Buy
47,000
+25,300
+117% +$201K ﹤0.01% 2993
2023
Q4
$127K Buy
21,700
+4,000
+23% +$23.4K ﹤0.01% 3243
2023
Q3
$45K Sell
17,700
-129,762
-88% -$330K ﹤0.01% 3421
2023
Q2
$369K Buy
147,462
+135,862
+1,171% +$340K ﹤0.01% 3032
2023
Q1
$24K Buy
11,600
+1,600
+16% +$3.31K ﹤0.01% 3796
2022
Q4
$16K Buy
+10,000
New +$16K ﹤0.01% 3996
2022
Q2
Sell
-13,300
Closed -$37K 4567
2022
Q1
$37K Buy
+13,300
New +$37K ﹤0.01% 3948